N-(4-methoxybenzyl)-N-phenylbenzene-1,2-diamine | 161455-85-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(4-methoxybenzyl)-N-phenylbenzene-1,2-diamine
• 英文别名: N-(4-Methoxybenzyl)-N'-phenyl-benzene-1,2-diamine；1-N-[(4-methoxyphenyl)methyl]-2-N-phenylbenzene-1,2-diamine
• CAS: 161455-85-2
• 化学式: C₂₀H₂₀N₂O
• 分子量: 304.392
• InChiKey: ZINOIAUUODTMQR-UHFFFAOYSA-N

物化性质

• 沸点：
  468.6±30.0 °C(Predicted)
• 密度：
  1.172±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  33.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-(4-methoxybenzyl)-N-phenylbenzene-1,2-diamine 在 锌 作用下， 以 四氢呋喃 、 溶剂黄146 为溶剂， 反应 19.0h， 生成 3-amino-1-(4-methoxybenzyl)-5-phenyl-1,5-dihydrobenzo<1,4>diazepine-2,4-dione
  参考文献：
  名称：

  Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”

  摘要：

  Directed screening of compounds selected from the Glare registry file for contractile activity on the isolated guinea pig gallbladder (GPGB) identified a series of 1,5-benzodiazepines with peripheral cholecystokinin (CCK) receptor agonist activity. Agonist efficacy within this series was modulated by variation of substituents on the N1-anilinoacetamide moiety. Remarkably, a single methyl group confers agonist activity, with an N-isopropyl substituent providing optimal efficacy. Hydrophilic substituents on the anilino nitrogen abolish agonist activity or produce antagonists of CCK. In contrast, hydrophilic electron-donating groups at the para-position of the anilino ring enhance or maintain in vitro and in vivo agonist activity. Despite decreased affinity for the human CCK-A receptor, relative to CCK-8, some of these compounds are equipotent to CCK as anorectic agents in rats following intraperitoneal administration.

  DOI：

  10.1021/jm950626d
• 作为产物：
  描述：

  邻氨基二苯胺 在 lithium aluminium tetrahydride 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 3.5h， 生成 N-(4-methoxybenzyl)-N-phenylbenzene-1,2-diamine
  参考文献：
  名称：

  Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”

  摘要：

  Directed screening of compounds selected from the Glare registry file for contractile activity on the isolated guinea pig gallbladder (GPGB) identified a series of 1,5-benzodiazepines with peripheral cholecystokinin (CCK) receptor agonist activity. Agonist efficacy within this series was modulated by variation of substituents on the N1-anilinoacetamide moiety. Remarkably, a single methyl group confers agonist activity, with an N-isopropyl substituent providing optimal efficacy. Hydrophilic substituents on the anilino nitrogen abolish agonist activity or produce antagonists of CCK. In contrast, hydrophilic electron-donating groups at the para-position of the anilino ring enhance or maintain in vitro and in vivo agonist activity. Despite decreased affinity for the human CCK-A receptor, relative to CCK-8, some of these compounds are equipotent to CCK as anorectic agents in rats following intraperitoneal administration.

  DOI：

  10.1021/jm950626d

文献信息

• Use of 1,5-benzo\x9bb!1,4-diazepines to control gastric emptying
  申请人：Glaxo Wellcome Inc.

  公开号：US05910495A1

  公开（公告）日：1999-06-08

  A method of controlling gastric emptying in patients having an early non-insulin-dependent diabetic condition and exhibiting rapid gastric emptying comprising the administration of an effective gastric emptying controlling amount of a compound of Formula (I) ##STR1## or a physiologically acceptable salt or solvate thereof.

  一种控制患有早期非胰岛素依赖型糖尿病病情且胃排空迅速的患者胃排空的方法，包括给予化合物的有效胃排空控制量，该化合物为下式（I）的化合物或其生理上可接受的盐或溶剂。
• [EN] 1,5-BENZODIAZEPINE DERIVATIVES HAVING CCK ANTAGONISTIC OR AGONISTIC ACTIVITY<br/>[FR] DERIVES DE 1,5-BENZODIAZEPINE PRESENTANT UNE ACTIVITE D'ANTAGONISTES OU D'AGONISTES POUR LA CCK
  申请人：GLAXO INC.

  公开号：WO1994024149A1

  公开（公告）日：1994-10-27

  (EN) Novel benzodiazepine compounds of formula (1) which exhibit agonistic activity for CCK-A receptors enabling them to modulate the hormones gastrin and cholecystokinin (CCK) in mammals for use in medicine as anorectic agents in the regulation of appetite, the treatment of obesity and the maintenance of weight loss.(FR) Nouveaux composés de benzodiazépine de formule (1) présentant une activité d'agonistes pour les récepteurs de la CCK-A leur permettant de moduler les hormones gastrine et cholécystoquinine (CCK) chez les mammifères. Lesdits composés sont destinés à être utilisés comme agents anorexiques dans la régulation de l'appétit, le traitement de l'obésité et la stabilisation de la perte de poids.

  （中文）公式（1）的新型苯二氮平类化合物表现出对CCK-A受体的激动作用，使它们能够在哺乳动物中调节胃泌素和胆囊收缩素（CCK）的激素，用于医学上的压食剂，以调节食欲，治疗肥胖和维持体重减轻。
• 1,5-BENZODIAZEPINE DERIVATIVES HAVING CCK ANTAGONISTIC AND OR AGONISTIC ACTIVITY
  申请人：GLAXO WELLCOME INC.

  公开号：EP0694039B1

  公开（公告）日：2001-01-24
• US5910495A
  申请人：——

  公开号：US5910495A

  公开（公告）日：1999-06-08